Off-target effects of c-MET inhibitors on thyroid cancer cells

Off-target effects of c-MET inhibitors on thyroid cancer cells

10.1158/1535-7163.MCT-13-0187

Saved in:

Bibliographic Details
Main Authors:	Zhou, Y., Zhao, C., Gery, S., Braunstein, G.D., Okamoto, R., Alvarez, R., Miles, S.A., Doan, N.B., Said, J.W., Gu, J., Phillip Koeffler, H.
Other Authors:	MEDICINE
Format:	Article
Published:	2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/125424
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo
by: Chan, D., et al.
Published: (2016)

Belinostat and panobinostat (HDACI): In vitro and in vivo studies in thyroid cancer
by: Chan, D., et al.
Published: (2014)

Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR
by: Garg, M., et al.
Published: (2014)

Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin
by: Garg, M, et al.
Published: (2020)

Meet. Met. Mat.
by: Ng, Kerin Jia En
Published: (2018)

Inecalcitol, an analog of 1α,25(OH) 2D 3, induces growth arrest of androgen-dependent prostate cancer cells
by: Okamoto, R., et al.
Published: (2016)

Will the Philippine Development Plan 2023-2028 Targets Be Met?
by: Felipe, Jesus
Published: (2023)

Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma
by: Thoennissen, N.H., et al.
Published: (2016)

Met-Tathione redused Glutathione
by: Ledesma, Melissa, et al.
Published: (2007)

When West met East...
by: Chiong, Cynthia, et al.
Published: (1985)

When Mnemosyne met Amihan
by: Alagao, Michellan Kristine Sarile
Published: (2010)

Understanding and targeting MET signaling in solid tumors - are We there yet?
by: Witthawat Ariyawutyakorn, et al.
Published: (2018)

Understanding and targeting MET signaling in solid tumors - are We there yet?
by: Ariyawutyakorn W., et al.
Published: (2017)

cMET and Refractive Error Progression in Children
by: Khor, C.C., et al.
Published: (2014)

Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor
by: Lim, S.-L., et al.
Published: (2021)

An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding
by: Sun, Q., et al.
Published: (2014)

Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets
by: Kanojia, D, et al.
Published: (2020)

Asia's huge appetite for fish: can it be met?
by: Donnellon-May, Genevieve, et al.
Published: (2022)

The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer
by: Aribi, A., et al.
Published: (2016)

Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma
by: Lee, D.H., et al.
Published: (2016)

BDNF Val66Met genotype and 6-month remission rates in late-life depression
by: Taylor, W.D., et al.
Published: (2014)

MET exon 14 deletion (METex14): Finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of "40 years of wilderness" and into a clear path of regulatory approval
by: Thanyanan Reungwetwattana, et al.
Published: (2018)

Social support in older individuals: The role of the BDNF Val66Met polymorphism
by: Taylor, W.D., et al.
Published: (2014)

MiR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway
by: Tan, S., et al.
Published: (2014)

Treatment with Met-RANTES reduces lung injury in caerulein-induced pancreatitis
by: Bhatia, M., et al.
Published: (2014)

The COMT Val158Met polymorphism and cognition in depressed and nondepressed older adults
by: Potter, G.G., et al.
Published: (2014)

Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
by: Sudo, M., et al.
Published: (2014)

MiR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
by: Yin, D., et al.
Published: (2016)

Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
by: Marijon, Hélène, et al.
Published: (2022)

Quantitative Structure-Activity Relationship Study Of Volitinib And Its Derivatives As A Highly Potent And Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor
by: Rifdi Bin Mohamad Fuzi, Mohamad

Involvement of c-Met/Hepatocyte Growth Factor Pathway in Cholangiocarcinoma Cell Invasion and Its Therapeutic Inhibition With Small Interfering RNA Specific for c-Met
by: Kawin Leelawat, et al.
Published: (2018)

The temperature dependence of the relaxation rates of off-centre Co 2+ ions in SrO
by: Hosea, T.J.C., et al.
Published: (2016)

A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma
by: Kong, Li Ren, et al.
Published: (2020)

Circadian rhythms and cancer
by: Gery, S., et al.
Published: (2011)

Role of the adaptor protein LNK in normal and malignant hematopoiesis
by: Gery, S., et al.
Published: (2016)

The bioassay of thyroid stimulating hormone in serum
by: C. Tantichareon, et al.
Published: (2018)

Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology
by: Teh, C.A., et al.
Published: (2014)

BDNF Val66Met polymorphism and serum concentrations of BDNF with smoking in Thai males
by: K. Suriyaprom, et al.
Published: (2018)

Gliptin Therapy Improve Adiponectin Levels in T2DM Mets
by: Jongky Hendro Prayitno, et al.
Published: (2014)

Thyroid functions in children with Down's syndrome
by: Unachak K., et al.
Published: (2014)